IMDX
Insight Molecular Diagnostics
IMDX
IMDX
20 hedge funds and large institutions have $20.4M invested in Insight Molecular Diagnostics in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
13% less funds holding
Funds holding: 23 → 20 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$54.7K | |
| 2 | +$32.2K | |
| 3 | +$20K | |
| 4 |
DC
Defender Capital
Charlotte,
North Carolina
|
+$11.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.56K |
Top Sellers
| 1 | -$30.7K | |
| 2 | -$18.3K | |
| 3 | -$4.63K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$1.48K |
| 5 |
RAM
Riggs Asset Management
Dallas,
Pennsylvania
|
-$148 |